These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31880220)

  • 21. Proceedings of the AMCP Partnership Forum: NCPDP Electronic Prior Authorization Standards-Building a Managed Care Implementation Plan.
    AMCP Electronic Prior Authorization Work Group
    J Manag Care Spec Pharm; 2015 Jul; 21(7):545-50. PubMed ID: 26108378
    [TBL] [Abstract][Full Text] [Related]  

  • 22. AMCP Partnership Forum: Driving Value and Outcomes in Oncology.
    J Manag Care Spec Pharm; 2017 May; 23(5):591-597. PubMed ID: 28448782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AMCP Partnership Forum: Racial health disparities-a closer look at benefit design.
    J Manag Care Spec Pharm; 2022 Jan; 28(1):125-131. PubMed ID: 34597158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AMCP Format dossier requests: manufacturer response and formulary implications for one large health plan.
    Spooner JJ; Gandhi PK; Connelly SB
    J Manag Care Pharm; 2007; 13(1):37-43. PubMed ID: 17269835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formulary management in the Department of Defense.
    Trice S; Devine J; Mistry H; Moore E; Linton A
    J Manag Care Pharm; 2009 Mar; 15(2):133-46. PubMed ID: 19236127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Current Status of Outcomes-Based Contracting for Manufacturers and Payers: An AMCP Membership Survey.
    Duhig AM; Saha S; Smith S; Kaufman S; Hughes J
    J Manag Care Spec Pharm; 2018 May; 24(5):410-415. PubMed ID: 29337604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacy formularies in integrated health systems.
    Osborne JA
    J Healthc Resour Manag; 1997; 15(1):18-20. PubMed ID: 10164678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AMCP Partnership Forum: Helping patients anticipate and manage drug costs.
    J Manag Care Spec Pharm; 2021 Jan; 27(1):127-132. PubMed ID: 33283615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AMCP Partnership Forum: Navigating Innovations in Diabetes Care.
    J Manag Care Spec Pharm; 2016 Dec; 22(12):1369-1375. PubMed ID: 27882834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluating the Training, Responsibilities, and Practices of P&T Committee Members and Nonmember Contributors.
    Rodriguez R; Kelly BJ; Moody M
    J Manag Care Spec Pharm; 2017 Aug; 23(8):868-874. PubMed ID: 28737984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Manufacturer response to AMCP Format dossier requests.
    Lyles A; Watkins JD
    J Manag Care Pharm; 2007 Apr; 13(3):290-1; author reply 291-2. PubMed ID: 17407398
    [No Abstract]   [Full Text] [Related]  

  • 32. PRACTITIONER UPDATE.
    Goldberg RB
    J Manag Care Spec Pharm; 2020 Apr; 26(4):341-349. PubMed ID: 32223609
    [No Abstract]   [Full Text] [Related]  

  • 33. AMCP Partnership Forum: Driving New Advances in Dyslipidemia Management.
    J Manag Care Spec Pharm; 2016 Apr; 22(4):426-33. PubMed ID: 27023696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prior Authorization and Utilization Management Concepts in Managed Care Pharmacy.
    2018-2019 Academy of Managed Care Pharmacy Professional Practice Committee
    J Manag Care Spec Pharm; 2019 Jun; 25(6):641-644. PubMed ID: 30977701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AMCP Partnership Forum: Biosimilars-policy, practice, and postmarketing surveillance to support treatment and coverage decisions.
    J Manag Care Spec Pharm; 2021 Oct; 27(10):1503-1508. PubMed ID: 34459234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DAKOTACARE's integrated medical and pharmacy management: enhancing value.
    Jones R
    S D Med; 2014 May; 67(5):209. PubMed ID: 24851471
    [No Abstract]   [Full Text] [Related]  

  • 37. Changes in P & T Committee function, role of pharmacists under managed care, and more.
    Hosp Formul; 1993 Dec; 28(12):963, 967-8, 970. PubMed ID: 10183991
    [No Abstract]   [Full Text] [Related]  

  • 38. Managing conflicts of interest in pharmacy and therapeutics committees: A proposal for multicentre formulary development.
    Friesen P; Caplan AL; Miller JE
    J Clin Pharm Ther; 2020 Apr; 45(2):249-255. PubMed ID: 31657022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The AMCP Format for Formulary Submissions: Welcome to Version 4.0.
    J Manag Care Spec Pharm; 2016 May; 22(5):444-6. PubMed ID: 27123906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A regional analysis of payer and provider views on cholesterol management: PCSK9 inhibitors as an illustrative alignment model.
    McCormick D; Bhatt DL; Bays HE; Taub PR; Caldwell KA; Guerin CK; Steinhoff J; Ahmad Z; Singh R; Moreo K; Carter J; Heggen CL; Sapir T
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1517-1528. PubMed ID: 33251993
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.